Curcuwin Highly Bioavailable Curcumin Obtains Self-Affirmed Gras

CurcuWIN highly bioavailable curcumin obtains self-affirmed GRAS

CurcuWIN is supported by a strong clinical and safety programme including in vitro, in vivo and multiple human clinical trials

OmniActive’s highly bioavailable curcumin, CurcuWIN, has received self-affirmed GRAS (Generally Recognised as Safe) notification by an expert panel who evaluated the ingredient in accordance with stringent US Food and Drug Administration (FDA) safety criteria.


Read More on Neutraceutical Business Review